CPMV
Mosaic ImmunoEngineering Inc.
Key Financials
Net Income
$-687846
↑ 25.4%
Gross Profit
$136753
N/A
Total Assets
$19882.00
↓ 86.0%
Operating Income
$-616119
↑ 30.0%
EPS (Diluted)
$-0.10
↑ 23.1%
Total Liabilities
$7.5M
↑ 8.2%
Shareholders' Equity
$-7476020.00
↓ 10.1%
Cash & Equivalents
$3622.00
↓ 96.9%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 10-Q | 5/20/2026 | View on SEC |
| NT 10-Q | 5/15/2026 | View on SEC |
| 10-K | 4/15/2026 | View on SEC |
| NT 10-K | 3/31/2026 | View on SEC |
| 10-Q | 11/19/2025 | View on SEC |
| NT 10-Q | 11/12/2025 | View on SEC |
| 10-Q | 8/19/2025 | View on SEC |
| NT 10-Q | 8/12/2025 | View on SEC |
| 10-Q | 5/20/2025 | View on SEC |
| NT 10-Q | 5/15/2025 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | CPMV |
| Company Name | Mosaic ImmunoEngineering Inc. |
| CIK | 836564 |
| Sector | Biological Products, (No Diagnostic Substances) |
| Industry | Non-accelerated filer Smaller reporting company |
| Exchange | OTC |
| SIC Code | 2836 |
| SIC Description | Biological Products, (No Diagnostic Substances) |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | 657-208-0890 |